Novo Nordisk Navigates a Market Split: European Reimbursement Gains Offset by Generic Erosion in Eme
France to reimburse Wegovy from June, unlocking 1M patients, but generic Ozempic in Brazil, India, Canada erodes pricing…
Novo Nordisk’s Brazilian Generic Setback Adds Urgency to ADA Pipeline Showcase
Brazil approves first generic Ozempic at 30% discount; Novo cuts Canada prices. All eyes on CagriSema Phase 3…
Novo Nordisk Faces Crosswinds: EU Approvals and Heart Data Offset Brazil Generic Threat and Pricing
Novo Nordisk stock near €38 as Brazil OKs generic Ozempic, EU clears 2 Wegovy variants, CV study shows…
Novo Nordisk Balances Amazon Access and Generic Onslaught as Pipeline Decision Looms
Novo Nordisk’s stock is squeezed between a landmark Amazon Pharmacy distribution deal and pricing erosion from Indian generics…
Novo Nordisk Faces First Generic Challenge in Canada as Wegovy Oral Pill Dominates US Market
Novo Nordisk’s US Wegovy surges with 65% of new scripts, raising guidance, but Canadian Ozempic generic approval threatens…
Generic Competition Meets a Pipeline Showcase
Novo Nordisk enters a critical period with Q1 earnings due May 6, a Canadian Ozempic generic launch, stock…
Teen Pill Success Meets Canadian Generic Shock
Novo Nordisk celebrates positive trial results for oral semaglutide in teens while facing first generic Ozempic competition in…
Novo Nordisk’s Hemophilia Breakthrough Fails to Distract From Canadian Generic Blow
Novo Nordisk’s stock slides 41% as Canada approves first generic Ozempic, while promising hemophilia data fails to lift…
Canadian Generic Launch and Q1 Results Loom
Health Canada authorizes Dr. Reddy’s biosimilar semaglutide, threatening Novo Nordisk’s Ozempic revenue as share buyback reaches 3.44 billion…
Novo Nordisk Juggles Pipeline Advances and Generic Threat as Share Buyback Hits $3.44 Billion
Novo Nordisk launches Phase 3 knee OA trial, gains FDA fast-track for heart drug, as first Ozempic generic…
Novo Nordisk’s Teen Pill Breakthrough and Canadian Generic Blow Arrive in the Same Week
Novo Nordisk faces a historic Ozempic generic in Canada while scoring a first-in-class oral GLP-1 win for teens,…
Eli Lilly’s Mounjaro loses ground to Novo Nordisk’s semaglutide, and the slew of cheaper generics
A Mounjaro injection used for weight loss procedures at a clinic in Mumbai, March 31, 2026. | Photo…